Cart
sales@molnova.com
2,4-dibroMobenzene-1,3,5-triol
CAS No. 84743-75-9
2,4-dibroMobenzene-1,3,5-triol( 2,4-dibromophloroglucinol | 2,4-Dibromo-1,3,5-benzenetriol )
Catalog No. M29551 CAS No. 84743-75-9
2,4-dibroMobenzene-1,3,5-triol is a marine derived natural products found in Rhabdonia verticillata.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 45 | In Stock |
|
| 10MG | 68 | In Stock |
|
| 25MG | 115 | In Stock |
|
| 50MG | 173 | In Stock |
|
| 100MG | 258 | In Stock |
|
| 200MG | 388 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name2,4-dibroMobenzene-1,3,5-triol
-
NoteResearch use only, not for human use.
-
Brief Description2,4-dibroMobenzene-1,3,5-triol is a marine derived natural products found in Rhabdonia verticillata.
-
Description2,4-dibroMobenzene-1,3,5-triol is a marine derived natural products found in Rhabdonia verticillata.
-
In Vitro——
-
In Vivo——
-
Synonyms2,4-dibromophloroglucinol | 2,4-Dibromo-1,3,5-benzenetriol
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number84743-75-9
-
Formula Weight283.9
-
Molecular FormulaC6H4Br2O3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESBrC1=C(O)C=C(O)C(Br)=C1O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Atrial Natriuretic P...
Auriculin A is a synthetic atrial?natriuretic?factor?(ANF) with hemodynamic effect. Auriculin A antagonizes renal vasoconstriction in the dog, and influences on arterial baroreflex control of heart rate, systemic blood pressure, and perfusion pressure in the hind limb (perfused at constant flow) in rabbits.
-
Roemerine
Roemerine is a potential active xanthine oxidase(XOD) inhibitor, XOD is a key enzyme in the pathogenesis of hyperuricemia and also a well-known target for the drug development to treat gout.
-
GSK329
GSK329 is an effective and selective inhibitor of TNNI3 Interacting Kinase (TNNI3K). GSK329 exhibits positive cardioprotective outcomes in the model of ischemia/reperfusion cardiac injury.
